Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 3;106(44):18792-7.
doi: 10.1073/pnas.0900589106. Epub 2009 Oct 21.

Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition

Affiliations

Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition

M Sloan Siegrist et al. Proc Natl Acad Sci U S A. .

Abstract

The Esx secretion pathway is conserved across Gram-positive bacteria. Esx-1, the best-characterized system, is required for virulence of Mycobacterium tuberculosis, although its precise function during infection remains unclear. Esx-3, a paralogous system present in all mycobacterial species, is required for growth in vitro. Here, we demonstrate that mycobacteria lacking Esx-3 are defective in acquiring iron. To compete for the limited iron available in the host and the environment, these organisms use mycobactin, high-affinity iron-binding molecules. In the absence of Esx-3, mycobacteria synthesize mycobactin but are unable to use the bound iron and are impaired severely for growth during macrophage infection. Mycobacteria thus require a specialized secretion system for acquiring iron from siderophores.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Construction of the mycobacterial esx-3 mutants. Schematic representation of the esx-3 loci from Mycobacterium smegmatis (upper) and in Mycobacterium tuberculosis/Mycobacterium bovis bacillus Calmette–Guérin (BCG) (lower) (A) and strategies used to generate the M. bovis BCG esx-3 conditional mutant (BCG-tet-esx-3) (B) and the M. smegmatis Δesx-3 mutant (C).
Fig. 2.
Fig. 2.
Esx-3 is required for Mycobacterium bovis bacillus Calmette–Guérin (BCG) and Mycobacterium smegmatis growth and for secretion of esx-3-encoded proteins under iron-deprived conditions. Growth of BCG-tet-esx-3 in iron-replete 7H9 medium or low iron glycerol alanine salts Tween-80 medium in the presence or absence of the inducer anhydrotetracycline (n = 3; **, P = 0.0002) (A). Growth of wild-type (WT) and Δesx-3 M. smegmatis in low iron (100 μM 2,2′-dipyridyl) or iron-replete (12.5 μM FeCl3) Sauton's medium (n = 3; **, P = 0.0014) (B). Strains were subcultured in low iron Sauton's medium before inoculation. Growth of fxbA and fxbA Δmsmeg0617 M. smegmatis containing pJEB402 with or without the msmeg0617 gene in low iron Sauton's medium (C). Strains were not subcultured before inoculation. Anti-c-myc and anti-ClpP1P2 immunoblotting of cell lysates and culture supernatants of WT and Δesx-3 M. smegmatis containing pTetG-esxGH-c-myc (D) or WT M. bovis BCG containing pMV762-esxG-6Xhis-esxH-c-myc (E) in low iron or iron-replete Sauton's medium. All data are representative of at least three independent experiments. Error bars represent the standard deviations.
Fig. 3.
Fig. 3.
Esx-3 interacts with the mycobactin pathway but is not required for sensing iron or for siderophore synthesis. (A) Growth of wild-type (WT), Δesx-3, exochelin (fxbA), and mycobactin (mbtD) insertional biosynthesis mutants and double mutants (fxbA Δesx-3 and fxbA mbtD) in low iron or iron-replete Sauton's medium (n = 3; *, P < 0.001). Strains were not subcultured before inoculation. (B) Quantitative RT-PCR for mbtB, mbtL, and irtA expression in WT and Δesx-3 Mycobacterium smegmatis (n = 3) in low iron (LI) or iron-replete (IR) medium and for mbtB in bacillus Calmette–Guérin (BCG)-tet-esx-3 in low iron medium. Data representative of three independent experiments are shown. Error bars represent the standard deviations. (C) The LC-MS analysis of lipids extracted from the whole cell lysates of M. smegmatis with chlorofrom and methanol yielded mycobactin chromatograms in which the m/z (881.4), elution time, and fragments (right) correspond to the expected and actual measurements of an authentic standard. Conditioned supernatants were subjected to LC-MS detection in mass windows corresponding to the known masses of carboxymycobactins [m/z (756.7–757.7) + 14n, where n is 0, 1, 2, 3, 4] and [m/z (757.7–758.7) + 14n] (upper). The elution time and collision-induced dissociation MS fragmentation (right) of the putative carboxymycobactins are consistent with those of an authentic carboxymycobactin standard.
Fig. 4.
Fig. 4.
Esx-3 is required for optimal utilization of iron-bound mycobactin. Growth curves for fxbA, fxbA mbtD, and fxbA Δesx-3 Mycobacterium smegmatis in low iron Sauton's medium (n = 3; **, P = 0.0005) (A), in the presence of 10 ng/mL ferri-mycobactin S (n = 3; **, P = 0.0017) (B), or 20 ng/mL ferri-carboxymycobactin S (n = 3; **, P = 0.0003) (C). All data are representative of at least three independent experiments. Error bars represent the standard deviations.
Fig. 5.
Fig. 5.
Esx-3 is required for mycobacterial infection of macrophages. Growth of wild-type (WT) M. bovis BCG and BCG-tet-esx-3 in the presence or absence of anhydrotetracycline in J774 macrophages (n = 3).

Similar articles

Cited by

References

    1. DiGiuseppe Champion PA, Cox JS. Protein secretion systems in Mycobacteria. Cell Microbiol. 2007;9:1376–1384. - PubMed
    1. Abdallah AM, et al. Type VII secretion—Mycobacteria show the way. Nat Rev Microbiol. 2007;5:883–891. - PubMed
    1. Cole ST, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–544. - PubMed
    1. Tekaia F, et al. Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber Lung Dis. 1999;79:329–342. - PubMed
    1. Gey Van Pittius NC, et al. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol. 2001;2:RESEARCH0044. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources